Abstract:Abstract Background Liver ischemia/reperfusion (I/R) injury is an inevitable pathological phenomenon in various clinical conditions, such as liver transplantation, resection surgery, or shock, which is the major cause of morbidity and mortality after operation. Ginkgo Biloba Dropping Pill (GBDP) is a unique Chinese Ginkgo Biloba leaf extract preparation that exhibits a variety of beneficial biological activities. The aim of this study is to investigate the protective effects of GBDP on the liver I/R injury both in the in vitro and in vivo. Methods Hypoxia/reoxygenation (H/R) experiments were performed in alpha mouse liver 12 (AML-12) cells and primary hepatocytes, which were pretreated with GBDP (60 or 120 µg/mL) followed by incubation in a hypoxia chamber. Cell viability was detected by 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT) assay. Annexin V staining as well as western blot analysis of apoptosis-related proteins was performed to detect the protective effect of GBDP on cell apoptosis induced by H/R injury. C57BL/6 mice were used to establish the liver I/R injury model, and were pretreated with GBDP (100 or 200 mg/kg/day, i.g.) for two weeks. The liver damage was evaluated by detection of plasma levels of alanine transaminase (ALT) and aspartate transaminase (AST), as well as histopathological examinations. Liver inflammation was determined by detecting the secretion of pro-inflammatory cytokines and neutrophil infiltration through enzyme-linked immunosorbent assay (ELISA) and myeloperoxidase (MPO) immunohistochemistry staining. Finally, Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick and labeling (TUNEL) staining and western blot analysis of apoptosis-related proteins were used to investigate the anti-apoptotic effect of GBDP in mice. Results In the in vitro study, GBDP pretreatment improved the cell viability of AML-12 cells in the H/R injury model. Similarly, the same result was found in the primary hepatocytes isolated from C57BL/6 mice. Moreover, GBDP decreased the number of apoptotic cells and reduced the expression of apoptosis-related proteins induced by H/R injury. In the in vivo study, oral administration of GBDP ameliorated liver injury evidenced by a significant decline in the levels of ALT and AST. Furthermore, the result of hematoxylin and eosin (H&E) staining showed that GBDP reduced the size of necrosis area in the liver tissue. In addition, the decreased infiltration of neutrophils and secretion of pro-inflammatory cytokines indicated that GBDP may play an anti-inflammatory effect. More importantly, GBDP reduced TUNEL-positive cells and the expression of apoptosis-related proteins in the liver indicating GBDP has anti-apoptotic effects. Conclusions Our findings elucidated that GBDP has potential effects for protecting against liver I/R injury characterized by its anti-apoptotic, anti-necrotic, and anti-inflammatory properties, which would promisingly make contributions to the exploration of therapeutic strategies in the liver I/R injury.

Therapeutic effects and molecular mechanisms of Ginkgo biloba extract on liver fibrosis in rats.

Therapeutic Effects and Molecular Mechanisms of Ginkgo Biloba Extract on Liver Fibrosis in Rats

[Effects of Nuclear Factor Kappab and Transforming Growth Factor Beta1 in the Anti-Liver Fibrosis Process Using Ginkgo Biloba Extract].

Ginkgo Biloba Extract Alleviates Liver Fibrosis Induced by Ccl4 in Rats

Prevented effect of Ginkgo Biloba extract an liver fibrosis of rat

Experimental Study on Ginkgo Bibloba Extract Reversing Carbon Tetrachloride-Induced Liver Fibrosis in Rats

Effects of extracts of ginkgo biloba (EGb) on CCl4 induced hepatic fibrosis in rats

Effects of Extract from Ginkgo Biloba on Carbon Tetrachloride-Induced Liver Injury in Rats

Effects of Ginkgo biloba extract on expression of NF-κB in rat liver fibrosis

Ginkgo Biloba Extract Reverses Ccl4-Induced Liver Fibrosis in Rats

Study on therapeutic effect of ginkgolides on rats with hepatic fibrosis

Effect of Ginkgo Bibloba Extract on Transforming Growth Factor-Β1 and Collagen Type Ⅰ in Hepatic Tissues of Experimental Hepatofibrosis Rats

Effects of Ginkgo Biloba Extracts (gbe) on Cyclooxygenase-2 in Liver of Rats with Hepatic Fibrosis

Experimental Study on Ginkgo Biloba Extract Against Carbon Tetrachloride-induced Chronic Liver Damage in Rats

Effect of ginkgo biloba extract on expression of Activin A in hepatic fibrosis of rat.

Protective Effects of Ginkgo Biloba Dropping Pills Against Liver Ischemia/reperfusion Injury in Mice

Effects of Ginkgo biloba extract on liver fibrosis induced by carbon tetrachloride in rats

PROTECTIVE EFFECT OF GINKGO BILOBA EXTRACT ON LIVERS IN AGING RATS

Antioxidant and Hepatoprotective Effects of Extract of Ginkgo Biloba in Rats of Non-Alcoholic Steatohepatitis.

Effects Of 18 Alpha-Glycyrrhizin On Tgf-Beta 1/Smad Signaling Pathway In Rats With Carbon Tetrachloride-Induced Liver Fibrosis

Ginkgo biloba extract alleviates CCl4-induced acute liver injury by regulating PI3K/AKT signaling pathway